HYOU1 and neoplasm: Tumor cells engineered to produce a secretable form of Grp170-stimulated DCs to produce the pro-inflammatory cytokine TNF-α, which supports the extracellular Grp170 as a potential immunostimulatory “danger” molecule (104).